Tags: Drug.

Ramucirumab (IMC-1121B trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. It is directed against the vascular endothelial growth factor receptor 2 (VEGFR2). By binding to VEGFR2 it works as a receptor antagonist blocking the binding of vascular endothelial growth factor (VEGF) to VEGFR2.

ATC prefix
none
CAS number
947687-13-0
FDA UNII code
D99YVK4L0X

Loading...

This page contains content from the copyrighted Wikipedia article "Ramucirumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.